Differential Treatment Effects for Renal Transplant Recipients With DSA-Positive or DSA-Negative Antibody-Mediated Rejection

BACKGROUND: Antibody-mediated rejection (ABMR) is the main cause of renal allograft loss. The most common treatment strategy is based on plasmapheresis plus the subsequent administration of intravenous immunoglobulin (IVIG). Unfortunately, no approved long-term therapy is available for ABMR. The cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Koslik, Marius Andreas, Friebus-Kardash, Justa, Heinemann, Falko Markus, Kribben, Andreas, Bräsen, Jan Hinrich, Eisenberger, Ute
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841765/
https://www.ncbi.nlm.nih.gov/pubmed/35174191
http://dx.doi.org/10.3389/fmed.2022.816555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841765/
https://www.ncbi.nlm.nih.gov/pubmed/35174191
http://dx.doi.org/10.3389/fmed.2022.816555

Ejemplares similares